97 related articles for article (PubMed ID: 38744826)
1. HAP40 modulates mutant Huntingtin aggregation and toxicity in Huntington's disease mice.
Chen L; Qin Y; Guo T; Zhu W; Lin J; Xing T; Duan X; Zhang Y; Ruan E; Li X; Yin P; Li S; Li XJ; Yang S
Cell Death Dis; 2024 May; 15(5):337. PubMed ID: 38744826
[TBL] [Abstract][Full Text] [Related]
2. TRIM37 is a primate-specific E3 ligase for Huntingtin and accounts for the striatal degeneration in Huntington's disease.
Qin Y; Chen L; Zhu W; Song J; Lin J; Li Y; Zhang J; Song X; Xing T; Guo T; Duan X; Zhang Y; Ruan E; Wang Q; Li B; Yang W; Yin P; Yan XX; Li S; Li XJ; Yang S
Sci Adv; 2024 May; 10(20):eadl2036. PubMed ID: 38758800
[TBL] [Abstract][Full Text] [Related]
3. Huntingtin structure is orchestrated by HAP40 and shows a polyglutamine expansion-specific interaction with exon 1.
Harding RJ; Deme JC; Hevler JF; Tamara S; Lemak A; Cantle JP; Szewczyk MM; Begeja N; Goss S; Zuo X; Loppnau P; Seitova A; Hutchinson A; Fan L; Truant R; Schapira M; Carroll JB; Heck AJR; Lea SM; Arrowsmith CH
Commun Biol; 2021 Dec; 4(1):1374. PubMed ID: 34880419
[TBL] [Abstract][Full Text] [Related]
4. Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington's disease.
Zhou Y; Peskett TR; Landles C; Warner JB; Sathasivam K; Smith EJ; Chen S; Wetzel R; Lashuel HA; Bates GP; Saibil HR
Acta Neuropathol Commun; 2021 Apr; 9(1):70. PubMed ID: 33853668
[TBL] [Abstract][Full Text] [Related]
5. AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease.
Miniarikova J; Zimmer V; Martier R; Brouwers CC; Pythoud C; Richetin K; Rey M; Lubelski J; Evers MM; van Deventer SJ; Petry H; Déglon N; Konstantinova P
Gene Ther; 2017 Oct; 24(10):630-639. PubMed ID: 28771234
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine-mediated ribotoxicity disrupts proteostasis and stress responses in Huntington's disease.
Aviner R; Lee TT; Masto VB; Li KH; Andino R; Frydman J
Nat Cell Biol; 2024 Jun; 26(6):892-902. PubMed ID: 38741019
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial protein import by mutant huntingtin.
Yano H; Baranov SV; Baranova OV; Kim J; Pan Y; Yablonska S; Carlisle DL; Ferrante RJ; Kim AH; Friedlander RM
Nat Neurosci; 2014 Jun; 17(6):822-31. PubMed ID: 24836077
[TBL] [Abstract][Full Text] [Related]
8. Correction of symptoms of Huntington disease by genistein through FOXO3-mediated autophagy stimulation.
Pierzynowska K; Podlacha M; Gaffke L; Rintz E; Wiśniewska K; Cyske Z; Węgrzyn G
Autophagy; 2024 May; 20(5):1159-1182. PubMed ID: 37992314
[TBL] [Abstract][Full Text] [Related]
9. Divalent cations promote huntingtin fibril formation on endoplasmic reticulum derived and model membranes.
Skeens A; Markle JM; Petipas G; Frey SL; Legleiter J
Biochim Biophys Acta Biomembr; 2024 Aug; 1866(6):184339. PubMed ID: 38763270
[TBL] [Abstract][Full Text] [Related]
10. Abnormal degradation of the neuronal stress-protective transcription factor HSF1 in Huntington's disease.
Gomez-Pastor R; Burchfiel ET; Neef DW; Jaeger AM; Cabiscol E; McKinstry SU; Doss A; Aballay A; Lo DC; Akimov SS; Ross CA; Eroglu C; Thiele DJ
Nat Commun; 2017 Feb; 8():14405. PubMed ID: 28194040
[TBL] [Abstract][Full Text] [Related]
11. Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.
Yu M; Fu Y; Liang Y; Song H; Yao Y; Wu P; Yao Y; Pan Y; Wen X; Ma L; Hexige S; Ding Y; Luo S; Lu B
Cell Res; 2017 Dec; 27(12):1441-1465. PubMed ID: 29151587
[TBL] [Abstract][Full Text] [Related]
12. Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.
Ratovitski T; O'Meally RN; Jiang M; Chaerkady R; Chighladze E; Stewart JC; Wang X; Arbez N; Roby E; Alexandris A; Duan W; Vijayvargia R; Seong IS; Lavery DJ; Cole RN; Ross CA
J Proteome Res; 2017 Aug; 16(8):2692-2708. PubMed ID: 28653853
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity.
Pan Y; Daito T; Sasaki Y; Chung YH; Xing X; Pondugula S; Swamidass SJ; Wang T; Kim AH; Yano H
Sci Rep; 2016 Aug; 6():31022. PubMed ID: 27516062
[TBL] [Abstract][Full Text] [Related]
14. mRNA nuclear clustering leads to a difference in mutant huntingtin mRNA and protein silencing by siRNAs
Allen S; O'Reilly D; Miller R; Sapp E; Summers A; Paquette J; Moreno DE; Bramato B; McHugh N; Yamada K; Aronin N; DiFiglia M; Khvorova A
bioRxiv; 2024 Apr; ():. PubMed ID: 38774633
[TBL] [Abstract][Full Text] [Related]
15. Mutant Huntingtin Disrupts the Nuclear Pore Complex.
Grima JC; Daigle JG; Arbez N; Cunningham KC; Zhang K; Ochaba J; Geater C; Morozko E; Stocksdale J; Glatzer JC; Pham JT; Ahmed I; Peng Q; Wadhwa H; Pletnikova O; Troncoso JC; Duan W; Snyder SH; Ranum LPW; Thompson LM; Lloyd TE; Ross CA; Rothstein JD
Neuron; 2017 Apr; 94(1):93-107.e6. PubMed ID: 28384479
[TBL] [Abstract][Full Text] [Related]
16. Distinct cellular toxicity of two mutant huntingtin mRNA variants due to translation regulation.
Xu H; An JJ; Xu B
PLoS One; 2017; 12(5):e0177610. PubMed ID: 28494017
[TBL] [Abstract][Full Text] [Related]
17. PET Ligands for Imaging Mutant Huntingtin Aggregates: A Case Study in Non-For-Profit Scientific Management.
Dickmann CGF; Milicevic Sephton S; Barker RA; Aigbirhio FI
Chembiochem; 2024 Jun; 25(11):e202400152. PubMed ID: 38695673
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific silencing of the gain-of-function mutation in Huntington's disease using CRISPR/Cas9.
Shin JW; Hong EP; Park SS; Choi DE; Seong IS; Whittaker MN; Kleinstiver BP; Chen RZ; Lee JM
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040815
[TBL] [Abstract][Full Text] [Related]
19. siRNA screen identifies QPCT as a druggable target for Huntington's disease.
Jimenez-Sanchez M; Lam W; Hannus M; Sönnichsen B; Imarisio S; Fleming A; Tarditi A; Menzies F; Dami TE; Xu C; Gonzalez-Couto E; Lazzeroni G; Heitz F; Diamanti D; Massai L; Satagopam VP; Marconi G; Caramelli C; Nencini A; Andreini M; Sardone GL; Caradonna NP; Porcari V; Scali C; Schneider R; Pollio G; O'Kane CJ; Caricasole A; Rubinsztein DC
Nat Chem Biol; 2015 May; 11(5):347-354. PubMed ID: 25848931
[TBL] [Abstract][Full Text] [Related]
20. Influence of species differences on the neuropathology of transgenic Huntington's disease animal models.
Li XJ; Li S
J Genet Genomics; 2012 Jun; 39(6):239-45. PubMed ID: 22749010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
